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Endogenous synthesis of oxalate is an important contributor
to calcium oxalate stone formation and renal impairment
associated with primary hyperoxaluria. Although the
principal precursor of oxalate is believed to be glyoxylate,
pathways in humans resulting in glyoxylate synthesis are not
well defined. Hydroxyproline, a component amino acid of
collagen, is a potential glyoxylate precursor. We have
investigated the contribution of dietary hydroxyproline
derived from gelatin to urinary oxalate and glycolate
excretion. Responses to the ingestion of 30 g of gelatin or
whey protein were compared on controlled oxalate diets.
The time course of metabolism of a 10 g gelatin load was
determined as well as the response to varying gelatin
loads. Urinary glycolate excretion was 5.3-fold higher on the
gelatin diet compared to the whey diet and urinary oxalate
excretion was 43% higher. Significant changes in plasma
hydroxyproline and urinary oxalate and glycolate were
observed with 5 and 10 g gelatin loads, but not 1 and 2 g
loads. Extrapolation of these results to daily anticipated
collagen turnover and hydroxyproline intake suggests that
hydroxyproline metabolism contributes 20–50% of glycolate
excreted in urine and 5–20% of urinary oxalate derived from
endogenous synthesis. Our results also revealed that the
kidney absorbs significant quantities of hydroxyproline and
glycolate, and their metabolism to oxalate in this tissue
warrants further consideration.
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The most common form of kidney stone is composed of
calcium oxalate. Oxalate excreted in urine is derived in
approximately equal parts from the diet and endogenous
synthesis.1 An increased endogenous production of oxalate in
the primary hyperoxalurias (PHs) not only dramatically
increases stone formation, but can in some individuals lead to
tissue deposition of calcium oxalate and renal failure. The
metabolic pathways that result in oxalate synthesis remain
unclear despite this clinical significance. In Type 1 and Type 2
PH, deficiencies in the glyoxylate metabolizing enzymes,
alanine:glyoxylate aminotransferase (AGT) and glyoxylate re-
ductase, respectively, result in excessive oxalate synthesis.2 The
sources of the glyoxylate, important in both Type 1 and Type 2
disease, have not been clearly identified. In Type 1 disease, the
glyoxylate derived from glycolate through the activity of
glycolate oxidase localized in liver peroxisomes is thought to
be the major source of oxalate synthesis. Sources of the glycolate,
however, have not been identified. Glyoxylate reductase activity,
present in both mitochondria and the cytoplasm, may be an
important source as it reduces glyoxylate to glycolate.
Hydroxyproline metabolism occurs principally in mito-
chondria of hepatocytes and renal proximal tubule cells, and
results in the formation of equal amounts of pyruvate and
glyoxylate.3,4 The daily turnover of collagen in humans is
estimated to be 2–3 g/day,4 leading to the metabolism of
240–420 mg of hydroxyproline and the formation of
140–240 mg of glyoxylate. Additional hydroxyproline may
be obtained from the diet, primarily through the ingestion of
collagen-containing meat products and gelatin-containing
foods. The ingestion of large amounts of hydroxyproline
increases the urinary excretion of oxalate and glycolate in
rats5–7 and pigs.8 The response of humans to large doses of
hydroxyproline is not known. This study was designed to
determine how human subjects metabolize hydroxyproline
derived from gelatin, as measured by changes in the urinary
excretion of oxalate and glycolate. An understanding of the
contribution of hydroxyproline metabolism to oxalate is
required to determine whether blocking this pathway would
be useful in limiting endogenous oxalate synthesis in
individuals with PH or calcium oxalate stone disease.
RESULTS
The mean circulating concentration of hydroxyproline in
individuals when consuming self-selected diets was
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13.275.7 mM (Table 1). A broad range of values was detected
spanning 4.8–23.8 mM, suggesting inter-individual differences
in collagen turnover, hydroxyproline metabolism, and/or
hydroxyproline intake. With the ingestion of 30 g of gelatin
containing 2.75 g hydroxyproline each day for 3 days,
hydroxyproline concentrations increased to a mean value of
117.9721.1 mM on the second day and 132.1720.7 mM on the
third day. Glycine plasma concentration was significantly
higher following ingestion of the gelatin compared to the
whey protein (Table 1). In contrast, alanine and serine did
not show significant changes compared to whey protein (data
not shown).
The mean oxalate and glycolate excretions following
ingestion of gelatin were significantly higher than those with
whey protein (Table 1). Glycolate excretion increased by 5.3-
fold and oxalate excretion increased by 43%. The difference
in glycolate and oxalate excretions on gelatin and whey diets
indicated that on a molar basis, approximately 5% of the
hydroxyproline metabolized was excreted as glycolate and
0.5% as oxalate. The urinary excretion of hydroxyproline
increased from 3.670.2 mg/day on day 3 of the whey diet to
14.275.2 mg/day on day 3 of the gelatin diet.
An analysis of the time course of metabolism of a 10 g
gelatin load revealed significant changes in plasma glycolate
over time that mirrored those of plasma hydroxyproline.
Both parameters peaked at 3 h and were still 33% greater than
fasting levels 24 h post load (Figure 1). Plasma oxalate levels
were highest at 3 h, but were not significantly different from
the fasting values (Figure 1). Urinary glycolate increased
significantly post load reaching a peak in the 4–6 h collection,
where glycolate levels were approximately eightfold greater
than fasting values (Figure 2). Urinary oxalate was signifi-
cantly higher at all post load collections compared to fasting
levels and reached a plateau at the 2–8 h collections (Figure 2).
The ratio of glycolate clearance relative to creatinine
clearance was calculated for each timed collection so as to
provide some insight into how the kidney handles filtered
glycolate. The mean clearance ratio for collection periods
from 0–8 h post 10 g gelatin load was 0.6370.21, indicating a
net reabsorption of glycolate (Figure 3).
The relationship between the amount of hydroxyproline
ingested and oxalate and glycolate excretion in a 6-h period
was assessed following loads containing 1–10 g of gelatin. The
results shown in Figure 4 indicate that there was a
proportional relationship between urinary oxalate and
glycolate excretion and the amount of gelatin ingested, but
significant increases in oxalate and glycolate excretion were
not observed at the lower gelatin doses. This finding was in
Table 1 | Mean 24 h urine oxalate, urine glycolate, and plasma hydroxyproline after consuming either self-selected diets
or diets containing either 30 g of gelatin or whey protein per day
Diet
Self-selected Whey Gelatin P-value (gelatin vs whey)
Oxalate (mg/g creatinine) 17.675.2 (12.2–26.1) 17.273.9 (10.5–23.7) 24.474.6 (17.0–33.0) o0.001
Glycolate (mg/g creatinine) 19.975.7 (12.2–34.9) 14.973.8 (5.0–21.8) 78.3733.1 (35.8–166.8) o0.001
Plasma hydroxyproline (mM) 13.275.7 (4.8–23.8) 14.674.5 (8.8–24.0) 125.0721.5 (97.8–162.2) o0.001
Plasma glycine (mM) ND 217.3769.6 (85.3–365.1) 515.87212.9 (306.1–958.5) o0.001
ND, not determined.
The urine results are the mean 24 h excretions on days 2 and 3 of the protein diets or on 3 days of a self-selected diet. Plasma values are the mean values of samples obtained
4 h after breakfast on days 2 and 3 of the protein diets or on 2 days of a self-selected diet. Ranges are indicated in parentheses.
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Figure 1 | Change in plasma hydroxyproline (inset), glycolate
(’), and oxalate (–m–) after ingestion of 10 g gelatin. Each time
point represents the mean7s.e.m. *Po0.05 for the comparison of
plasma glycolate or hydroxyproline at each post load collection time
with the corresponding fasting value.
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Figure 2 | Urinary glycolate (’) and urinary oxalate (–m–)
following ingestion of 10 g gelatin. Each collection represents the
mean7s.e.m. *Po0.05 for the comparison of urinary glycolate or
oxalate at each post load collection period with the corresponding
fasting value.
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keeping with plasma hydroxyproline measurements, which
did not show significant increases at the lower gelatin doses
(Figure 4).
DISCUSSION
The mean circulating concentration of hydroxyproline we
determined in individuals on self-selected diets, 13.2 mM, is
similar to other reported mean values in the range of
10–15 mM.9,10 Although collagen turnover in the body is a
major source of hydroxyproline, significant amounts of
hydroxyproline may also be ingested in meats and gelatin-
containing foods. Ground beef may contain up to 7%
collagen, for instance.11 Collagen supplements are also
promoted for the health of skin, bone, and joints, and as a
weight loss agent, and may be a significant source of
hydroxyproline for some individuals. If there is a linear
relationship between the amount of hydroxyproline metabo-
lized and the amounts of glycolate and oxalate produced, and
if 2–5 g of collagen/gelatin are broken down each day, the
results in Figure 4 suggest that this will result in the
production of approximately 1–3 mg oxalate and 10–20 mg of
glycolate per day. This could account for 20–50% of the
glycolate excreted in urine and 5–20% of the endogenous
oxalate produced in the body each day, if it is assumed that
50% of urinary oxalate, B15 mg/day, is derived from
endogenous synthesis.
The possible fates of glyoxylate produced from the
metabolism of hydroxyproline are illustrated in Figure 5.
The steps shown apply to human liver tissue where AGT1 is
localized in peroxisomes. In other species, including the rat
and mouse, AGT1 may also be localized in mitochondria.
The dual localization in these rodents and a much lower
AGT1 activity compared to human tissue suggests that
caution must be exercised when extrapolating any results of
experiments involving glyoxylate metabolism in these species
to humans. Kidney and heart tissue also possess the enzymes
required for hydroxyproline breakdown.4,12,13 As only 5% of
the ingested hydroxyproline was recovered in urine as
glycolate and oxalate, the bulk of the glyoxylate produced
from hydroxyproline metabolism was most likely converted
to glycine. Although plasma glycine had doubled after
ingestion of gelatin, the glycine produced from hydroxy-
proline metabolism could not be determined as gelatin
contains high amounts of glycine. The absence of AGT1
activity in individuals with PH1 provides further insight into
the magnitude of this pathway as the conversion of glyoxylate
to glycine is blocked. The combined urinary excretion of
glycolate and oxalate in these individuals is usually in the
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Figure 3 | The ratio of glycolate clearance to creatinine clearance
following 10 g load of gelatin. Each collection represents the
mean7s.e.m.
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Figure 4 | Increases in urinary oxalate (’) and glycolate (&)
excretion over fasting levels in a 6-h period following ingestion
of various loads of gelatin. Increases in urinary oxalate and
glycolate excretion were calculated by subtracting three times the
fasting 2 h levels from the total amount measured in each collection.
Plasma hydroxyproline (inset) was measured 3 h after ingestion of
each load. The asterisk denotes significantly higher (Po0.05) values
compared to the 0 g gelatin load. Each parameter represents the
mean7s.e.m.
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Figure 5 | Hydroxyproline transport and metabolism in hepato-
cytes. Hyp, trans-4-hydroxy-L-proline; GR, glyoxylate reductase;
DAO, D-amino oxidase; AGT, alanine:glyoxylate aminotransferase;
GO, glycolate oxidase; LDH, lactate dehydrogenase.
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range of 200–500 mg/day. If daily collagen turnover is indeed
2–3 g/day and the ingestion of some hydroxyproline occurs,
hydroxyproline metabolism may contribute to the bulk of
their oxalate and glycolate excretion. The combined excretion
of oxalate and glycolate is much less in individuals with PH2,
implying that AGT1 may convert a significant amount of the
glyoxylate produced from hydroxyproline metabolism to
glycine.
Of interest also is the potential renal metabolism of
hydroxyproline. If the circulating hydroxyproline concentra-
tion is 10 mM and the glomerular filtration rate is 100 ml/min,
188 mg of hydroxyproline would be filtered each day.
Following ingestion of 30 g of whey protein, mean urinary
hydroxyproline was only 4 mg per day. This is in close
agreement with a previous study, which reported thato5 mg
hydroxyproline is normally excreted in urine per day.14 These
data indicate that the bulk of filtered hydroxyproline is
reabsorbed by the kidney. Furthermore, our data showed that
plasma hydroxyproline following the ingestion of 30 g gelatin
increased to approximately 100 mM. Thus, the filtered load on
the kidney would increase to 1.88 g/day. Urine hydroxypro-
line measurements showed that only 14 mg hydroxyproline
was excreted following ingestion of 30 g gelatin. This
indicates that even at 10 times the normal filtered load of
hydroxyproline per day, the kidney reabsorbs over 99%.
Some hydroxyproline may be metabolized in the renal cortex
as it contains enzymes in the hydroxyproline degradation
pathway.12 Based on the relative weights of the tissues and
their activities, it might be expected that 15% of the
hydroxyproline is metabolized in the renal cortex. The
kidney contains glyoxylate reductase activity and can there-
fore convert hydroxyproline-derived glyoxylate to glyco-
late.15,16 The organ lacks AGT1 activity, but does contain
AGT2 activity, which has a much lower affinity for glyoxylate
than AGT1.17 Thus, in comparison to the liver, the kidney
may have a reduced capacity to convert glyoxylate to glycine.
AGT2 has no homology with AGT1, is found in mitochon-
dria of most tissues, and has D-3-aminobutyrate:pyruvate
aminotransferase, b-alanine:pyruvate aminotransferase and
dimethylarginine:pyruvate aminotransferase activities, as well
as AGT activity. Lowry et al.12 reported that isolated rat
proximal tubules can convert hydroxyproline-derived glyox-
ylate to glycine. Whether any glyoxylate is converted to
oxalate and whether the kidney is a significant source of
endogenous oxalate synthesis remains to be determined.
Much of the hydroxyproline reabsorbed by the kidney may
return to the circulation, as hydroxyproline levels were 33%
higher than the original fasting levels 24 h after the ingestion
of 10 g gelatin. These results also suggest that this load of
gelatin exceeded the body’s capacity to rapidly metabolize the
free hydroxyproline it produced.
The studies we have performed also provide some insight
into glycolate production, its clearance, and its potential
renal metabolism. We have previously reported that an
average 39 mg of glycolate is excreted by individuals on self-
selected diets.18 This is in close agreement to this study,
where a mean of 35 mg glycolate was excreted by study
subjects per day when on self-selected diets. Harris and
Richardson19 estimated that the mean daily glycolate intake is
33 mg. They further provided evidence that glycolate is
efficiently absorbed and metabolized in rats, suggesting that
the glycolate excreted in human urine was derived pre-
dominantly from the diet. Their method for glycolate analysis
in food extracts utilized a nonspecific colorimetric procedure.
Analyses in our laboratory by ion chromatography coupled
with electrospray mass spectrometry detection of mush-
rooms, peaches, and coffee, which Harris and Richardson
found to contain some of the highest glycolate levels of the
foods they tested, indicated that their values were over-
estimated 25- to 50-fold (J Knight and RP Holmes,
unpublished results). Our results indicated that in fasting
subjects, the mean circulating glycolate concentration was
6.5 mM, and reached 10 mM 4 h after a meal. We speculate that
the bulk of this glycolate is derived from metabolism and not
from the diet. Assuming an average plasma glycolate
concentration of 7.5 mM during the day and a glomerular
filtration rate of 100 ml/min, 82 mg is filtered each day. It
appears, therefore, that half of the filtered glycolate is
reabsorbed and presumably metabolized, and the other half
excreted in urine. The average clearance ratio of 0.6 in these
studies supports these calculations. The higher clearance ratio
reported here is likely due to the increased glycolate load on
the kidney from ingestion of hydroxyproline and its
metabolism to glycolate. Whether this glycolate is oxidized
in part to oxalate warrants further investigation. We have
observed that both rat and human renal tissue contain
glycolate oxidase activity that may be due to the presence of
large amounts of HAOX2 (long-chain hydroxy-fatty acid
oxidase), which has some affinity for glycolate (Holmes RP,
unpublished results).
Whereas these studies indicate that hydroxyproline
metabolism is likely to be a significant source of glyoxylate
production in humans, a more definitive picture of the
contribution of hydroxyproline metabolism to daily glycolate
and oxalate synthesis may only emerge by following the
metabolism of isotopic hydroxyproline. Better quantitative
evidence is required to determine if blocking this metabolic
pathway would be useful in limiting oxalate synthesis in
patients with PH or calcium oxalate stone disease.
MATERIALS AND METHODS
Subjects
Healthy subjects with no history of nephrolithiasis were recruited
from Wake Forest University Medical Center. Subjects provided
informed consent before participating in this study, which was
approved by the Institutional Review Board. All subjects had a body
mass index o27. In addition, they were not taking any medications
or dietary supplements and refrained from vigorous exercise.
Gelatin/whey study
Ten subjects (five male and five female subjects; mean age, 3274
years; age range, 28–39 years) participated in the study. Subjects were
initially asked to collect three consecutive 24 h urines while
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consuming self-selected diets. On the last 2 days of this portion of
the study, blood was drawn 4 h after breakfast. Following these
collections, subjects consumed diets controlled in its content of
calories, fat, protein, carbohydrate, calcium, magnesium, sodium,
phosphorus, and oxalate, as described previously,1 for two 5-day
periods separated by at least a 1-week washout period. During one
5-day period, the diet contained a quarter of its protein as gelatin
(Knox). The second 5-day period of the diet contained a quarter of
its protein as whey. The hydroxyproline content of the gelatin,
measured by AAA Laboratory (Mercer Island, WA, USA), was 9.17 g
per 100 g, and the whey protein was free of hydroxyproline. Ten
grams of either gelatin or whey protein were provided as dry
powders mixed in with cranberry juice with each meal. On the final
3 days of the gelatin and whey diet period, each subject provided a
blood sample 4 h after breakfast and collected 24 h urines.
Controlled diets were prepared in the metabolic kitchen of the
institutional General Clinical Research Center. The calcium content
was targeted at 1000 mg/2500 kcal and the oxalate content 150 mg/
2500 kcal. This oxalate content is within the reported range of
normal oxalate intake.20 Diets were adjusted to within 5% of these
amounts, and with a ratio of calcium to oxalate in each meal 45:1.
Each diet contained 15–16% protein, 29–30% fat, and 54–55%
carbohydrate. To closely control the volume of urine, subjects drank
only the fluids provided, which included 2 l of bottled water per day.
Sodium, calcium, magnesium, phosphate, uric acid, citrate, and
urea were measured in urine samples as described previously.18
These measurements provided a means of assessing subject
compliance with the dietary protocol.
Gelatin-loading studies
Six subjects (three male and three female subjects; mean age, 2877
years; age range, 23–42 years) were recruited for this study to
investigate the effect of varying gelatin loads on glycolate and oxalate
in plasma and urine, and the time course of metabolism of
hydroxyproline over 24 h following a 10 g gelatin load. Throughout
this study subjects were on self-selected diets, but were required to
avoid oxalate-rich foods and eat moderate amounts of protein and
calcium. The day before each load, subjects fasted overnight (14 h).
A fasting 2 h urine collection was obtained with a blood sample at
the midpoint of this collection. Gelatin was provided as a dry
powder mixed with 6 ounces of yogurt and was consumed at
breakfast along with a sausage biscuit and 250 ml water. Gelatin
loads of 0, 1, 2, 5, and 10 g of gelatin were tested. Each load was
separated by at least 2 days. Urine was collected for 6 h and blood
was drawn 3 h after ingestion of each load. The time course of
changes in plasma hydroxyproline, oxalate, and glycolate levels and
the urinary excretion of oxalate and glycolate was examined on a
10 g load. Four sequential 2 h urine collections were obtained after
the 10 g load together with a blood sample at the midpoint of each
collection. Over the next 16 h, subjects obtained an evening
collection (6 h) and another in the morning of the following day
(10 h). Subjects were required to drink 250 ml bottled water per
hour over the 6-h period following gelatin loads, and the initial 8-h
period after the 10 g load to ensure good urine output.
Plasma and urine analyses
Blood samples were obtained by venipuncture into heparinized
tubes and immediately centrifuged at 41C for 10 min (1500 g). If not
analyzed the same day, plasma samples were stored at 801C.
Plasma was filtered using acid washed Ultrafree-MC centrifugal
filters (Millipore Corp., Bedford, MA, USA) with a 10 000 nominal
molecular weight limit. Twenty-four urine collections were
collected in boric acid. For oxalate analysis, urines were diluted in
2 mM HCl before storage at 801C. Total urine oxalate and plasma
oxalate were determined by ion chromatography, as described
previously.21,22
Urine and plasma glycolate were determined by ion chromato-
graphy coupled with electrospray mass spectrometry (Dionex Corp.,
Sunnyvale, CA, USA). The ion chromatography equipment
consisted of a Dionex ED50 conductivity detector, Dionex AS11_HC
2 250-mm ion exchange column with guard column at a contro-
lled temperature of 301C, and a Dionex ASRS-ULTRA 2-mm
suppressor. A sodium hydroxide gradient 0.5–1 mM over 25 min at a
flow rate of 0.4 ml/min was used to separate glycolate from the other
sample anions, which enabled sensitive quantitation of glycolate by
mass detection. The limit of detection, defined as the mean blank
signal plus 10 times the s.d. of the blank, was 1 pmole (0.2 mM). A
typical calibration curve for glycolate measured by mass detection is
shown in Figure 6. A linear response was obtained up to 10 mM. The
intra-sample coefficient of variation (n¼ 6) for the measurement of
glycolate in urine and plasma was 4.1 and 6.1%, respectively. The
mean recovery of 10 mM glycolate added to four different plasma
samples was 10575%, range 101–110%. The mean recovery of
50 mM glycolate added to four different urine samples was
10377.5%, range 99–112%, respectively. Amino-acid analysis was
performed by the AccQ.Tag method (Waters Corp., Milford, MA,
USA), as described previously.23
Statistical analyses
Results are presented as mean values7s.d., unless otherwise
indicated. The statistical significance of results was assessed by
analysis of variance and considered significant if P-values were 0.05
or less. The Holm–Sidak method was used to correct for multiple
comparisons and all assays were conducted using SigmaStat (Systat
Software Inc., Richmond, CA, USA).
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